Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP217662.RAtvIPG3eRXZHT4GBKsxyPwwxoNoMHJE5iDkT9hFn91go130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP217662.RAtvIPG3eRXZHT4GBKsxyPwwxoNoMHJE5iDkT9hFn91go130_assertion type Assertion NP217662.RAtvIPG3eRXZHT4GBKsxyPwwxoNoMHJE5iDkT9hFn91go130_head.
- NP217662.RAtvIPG3eRXZHT4GBKsxyPwwxoNoMHJE5iDkT9hFn91go130_assertion description "[Utilizing neuroendocrine tumor samples, we found that the frequency as well as the average intensity of the expression of PAX5 increased from pulmonary carcinoid (9%, moderate and strong PAX5 expression, n=44), to large-cell neuroendocrine carcinoma (LCNC, 27%, n=11) to SCLC (33%, n=76).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217662.RAtvIPG3eRXZHT4GBKsxyPwwxoNoMHJE5iDkT9hFn91go130_provenance.
- NP217662.RAtvIPG3eRXZHT4GBKsxyPwwxoNoMHJE5iDkT9hFn91go130_assertion evidence source_evidence_literature NP217662.RAtvIPG3eRXZHT4GBKsxyPwwxoNoMHJE5iDkT9hFn91go130_provenance.
- NP217662.RAtvIPG3eRXZHT4GBKsxyPwwxoNoMHJE5iDkT9hFn91go130_assertion SIO_000772 19139719 NP217662.RAtvIPG3eRXZHT4GBKsxyPwwxoNoMHJE5iDkT9hFn91go130_provenance.
- NP217662.RAtvIPG3eRXZHT4GBKsxyPwwxoNoMHJE5iDkT9hFn91go130_assertion wasDerivedFrom befree-20140225 NP217662.RAtvIPG3eRXZHT4GBKsxyPwwxoNoMHJE5iDkT9hFn91go130_provenance.
- NP217662.RAtvIPG3eRXZHT4GBKsxyPwwxoNoMHJE5iDkT9hFn91go130_assertion wasGeneratedBy ECO_0000203 NP217662.RAtvIPG3eRXZHT4GBKsxyPwwxoNoMHJE5iDkT9hFn91go130_provenance.